A clinical trial of adjunctive Celecoxib treatment in patients with major depression: a double-blind, placebo controlled trial.

Trial Profile

A clinical trial of adjunctive Celecoxib treatment in patients with major depression: a double-blind, placebo controlled trial.

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Celecoxib (Primary) ; Fluoxetine (Primary)
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Apr 2012 Additional lead trial centre identified as reported by Iranian Registry of Clinical Trials.
    • 05 Apr 2012 Trial phase changed from III to II/III as reported by Iranian Registry of Clinical Trials.
    • 05 Apr 2012 Planned end date (20 Apr 2009) added as reported by Iranian Registry of Clinical Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top